FDA approves Tivicay, a new drug to treat HIV-1 infection
PRESS RELEASE The U.S. Food and Drug Administration today approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection. Tivicay is an integrase strand transfer inhibitor that interferes with one of the enzymes More...